this post was submitted on 16 Dec 2025
2 points (100.0% liked)

China News

72 readers
8 users here now

A community for china news

founded 1 month ago
MODERATORS
rss@news.abolish.capital
Salamence@lemmy.zip
RedWizard@news.abolish.capital
2
China’s new drug insurance: lifeline for patients or squeeze on big pharmaceutical firms? (www.scmp.com)
submitted 4 days ago by rss@news.abolish.capital to c/china@news.abolish.capital
0 comments fedilink hide all child comments
 

Mainland China’s 17 million Alzheimer’s patients can, for the first time, pay less out of pocket for a costly drug touted as “historic” and “the beginning of the end” for the memory-robbing disease after Beijing launched a commercial insurance innovative drug list in an effort to make medicines more accessible and affordable. Leqembi, developed by Japan’s Eisai and costing a mainland Chinese patient about US$28,400 a year, could see its price cut by half after it was added to the inaugural...

From China - South China Morning Post via This RSS Feed.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here